Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Pittenger & Anderson Inc.

Pittenger & Anderson Inc. grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 2,000.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,323 shares of the biotechnology company’s stock after acquiring an additional 1,260 shares during the period. Pittenger & Anderson Inc.’s holdings in Axon Enterprise were worth $342,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. BKM Wealth Management LLC bought a new position in shares of Axon Enterprise during the fourth quarter worth about $32,000. Key Financial Inc lifted its position in shares of Axon Enterprise by 367.6% during the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after purchasing an additional 125 shares during the last quarter. Lindbrook Capital LLC lifted its holdings in Axon Enterprise by 43.3% in the fourth quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after acquiring an additional 52 shares during the last quarter. Rakuten Securities Inc. bought a new position in Axon Enterprise in the fourth quarter worth about $48,000. Finally, Provence Wealth Management Group bought a new position in Axon Enterprise in the third quarter worth about $80,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on AXON shares. Argus began coverage on shares of Axon Enterprise in a report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 target price on the stock. Barclays lifted their price target on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research report on Thursday, February 29th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Morgan Stanley raised their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 28th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $312.64.

Read Our Latest Research Report on Axon Enterprise

Axon Enterprise Stock Up 1.3 %

AXON traded up $3.83 during midday trading on Thursday, reaching $306.24. 297,871 shares of the company were exchanged, compared to its average volume of 469,482. The company has a market cap of $23.11 billion, a price-to-earnings ratio of 133.72 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The company’s fifty day moving average price is $302.15 and its 200 day moving average price is $260.29. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The company had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. As a group, analysts expect that Axon Enterprise, Inc. will post 2.44 EPS for the current year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.